compared to a few decades back when mantle cell lymphoma was really seen as a poor prognosis disease, we're seeing patients do a lot better. But obviously the next frontier, as it were ...

“With today’s approval, Calquence provides a critical new treatment option to mantle cell lymphoma patients in the US, with Calquence proven to deliver nearly one and a half years of ...

2025 – The FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL ... in the United States. While patients usually respond to early treatment ...

I think we're still a little concerned that it's not as durable as we see in large cell lymphoma, but certainly can profoundly impact the disease biology and change the trajectory of patients who ...